skip to content

International Development Research @ Cambridge

 

Scientists attending a recent meeting of the American Society for Microbiology reported they had uncovered a highly disturbing trend. They revealed that bacteria containing a gene known as mcr-1 – which confers resistance to the antibiotic colistin – had spread round the world at an alarming rate since its original discovery 18 months earlier. In one area of China, it was found that 25% of hospital patients now carried the gene.

Colistin is known as the “antibiotic of last resort”. In many parts of the world doctors have turned to its use because patients were no longer responding to any other antimicrobial agent. Now resistance to its use is spreading across the globe.

In the words of England’s chief medical officer, Sally Davies: “The world is facing an antibiotic apocalypse.” Unless action is taken to halt the practices that have allowed antimicrobial resistance to spread and ways are found to develop new types of antibiotics, we could return to the days when routine operations, simple wounds or straightforward infections could pose real threats to life, she warns.

 

For further details, please see the full source article on the Guardian website here.

Welcome to Cambridge Global Challenges

Cambridge Global Challenges is the Interdisciplinary Research Centre (IRC) of the University of Cambridge that aims to enhance the contribution of its research towards addressing the Sustainable Development Goals (SDGs) by 2030, with a particular focus on the poorest half of the world’s population.

 

Join the Interdisciplinary Research Centre

Register to Cambridge Global Challenges and to the IRC's mailing list here.

 

Learn about the support we provide 

Learn how Cambridge Global Challenges can support your research here.

 

Contact us

coordinator@gci.cam.ac.uk​